162 related articles for article (PubMed ID: 24498382)
1. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract][Full Text] [Related]
3. The Potential Pharmacological Effects of Natural Product Withaferin A in Cancer: Opportunities and Challenges for Clinical Translation.
Devabattula G; Panda B; Yadav R; Godugu C
Planta Med; 2024 May; 90(6):440-453. PubMed ID: 38588695
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors.
Ancona P; Trentini A; Terrazzan A; Grassilli S; Navals P; Gates EWJ; Rosta V; Cervellati C; Bergamini CM; Pignatelli A; Keillor JW; Taccioli C; Bianchi N
J Mol Biol; 2024 May; 436(10):168569. PubMed ID: 38604527
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives.
Behl T; Sharma A; Sharma L; Sehgal A; Zengin G; Brata R; Fratila O; Bungau S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33291236
[TBL] [Abstract][Full Text] [Related]
6. Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform.
Moon HR; Ospina-Muñoz N; Noe-Kim V; Yang Y; Elzey BD; Konieczny SF; Han B
PLoS One; 2020; 15(6):e0234012. PubMed ID: 32544183
[TBL] [Abstract][Full Text] [Related]
7. Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.
Cavaleri F; Chattopadhyay S; Palsule V; Kar PK; Chatterjee R
Integr Cancer Ther; 2024; 23():15347354231223499. PubMed ID: 38281118
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A-Encapsulated PEGylated Nanoliposomes Induce Apoptosis in B16F10 Melanoma Cells by Regulating Bcl2 and Bcl xl Genes and Mitigates Murine Solid Tumor Development.
Abeesh P; Guruvayoorappan C
J Environ Pathol Toxicol Oncol; 2024; 43(2):29-42. PubMed ID: 38505911
[TBL] [Abstract][Full Text] [Related]
9. Development of a cancer metastasis-on-chip assay for high throughput drug screening.
Ozer LY; Fayed HS; Ericsson J; Al Haj Zen A
Front Oncol; 2023; 13():1269376. PubMed ID: 38239643
[TBL] [Abstract][Full Text] [Related]
10. Withanone as an Emerging Anticancer Agent and Understanding Its Molecular Mechanisms: Experimental and Computational Evidence.
Stephen A; Tune BXJ; Wu YS; Batumalaie K; Sekar M; Sarker MMR; Subramaniyan V; Fuloria NK; Fuloria S; Gopinath SCB
Curr Cancer Drug Targets; 2024 Mar; ():. PubMed ID: 38494932
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.
Heyninck K; Lahtela-Kakkonen M; Van der Veken P; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2014 Oct; 91(4):501-9. PubMed ID: 25159986
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Szarc Vel Szic K; Declerck K; Crans RAJ; Diddens J; Scherf DB; Gerhäuser C; Vanden Berghe W
Oncotarget; 2017 Jun; 8(25):40434-40453. PubMed ID: 28467815
[TBL] [Abstract][Full Text] [Related]
13. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells.
Kakar SS; Ratajczak MZ; Powell KS; Moghadamfalahi M; Miller DM; Batra SK; Singh SK
PLoS One; 2014; 9(9):e107596. PubMed ID: 25264898
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera: From prevention to treatment of cancer.
Palliyaguru DL; Singh SV; Kensler TW
Mol Nutr Food Res; 2016 Jun; 60(6):1342-53. PubMed ID: 26718910
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
Rai M; Jogee PS; Agarkar G; dos Santos CA
Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
[TBL] [Abstract][Full Text] [Related]
16. Axl is a novel target of withaferin A in the induction of apoptosis and the suppression of invasion.
Woo SM; Min KJ; Kim S; Park JW; Kim DE; Kim SH; Choi YH; Kwon TK
Biochem Biophys Res Commun; 2014 Aug; 451(3):455-60. PubMed ID: 25117439
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells.
Li X; Zhu F; Jiang J; Sun C; Wang X; Shen M; Tian R; Shi C; Xu M; Peng F; Guo X; Wang M; Qin R
Cancer Lett; 2015 Feb; 357(1):219-230. PubMed ID: 25444914
[TBL] [Abstract][Full Text] [Related]
20. Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.
Khazal KF; Hill DL; Grubbs CJ
Anticancer Res; 2014 Nov; 34(11):6327-32. PubMed ID: 25368231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
